Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs

被引:11
作者
Jeong, Geon [1 ,2 ,3 ]
Lim, Yeong-Hwan [1 ,2 ,3 ]
Kim, Nam Joong [1 ,2 ,3 ]
Wee, Gabbine [4 ]
Kim, Young-Kook [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Dept Biochem, Sch Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Sch Med, Gwangju, South Korea
[3] Chonnam Natl Univ, Basic Res Lab Cardiac Remodeling, Sch Med, Gwangju, South Korea
[4] Daegu Gyeongbuk Med Innovat Fdn, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
Knockout; microRNA; miR-221; miR-222; TALEN; CARCINOMA-CELL-LINES; MICRORNAS; P27(KIP1); CANCER;
D O I
10.1080/15476286.2016.1269994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) regulate the expression of mRNA through sequence-specific binding of the 3 untranslated region (UTR). The seed sequence of miRNAs is the key determinant for target site recognition. Paralogous miRNAs, which share the same seed sequences but differ in their 3 regions, are known to regulate largely overlapping groups of mRNAs. However, no study has analyzed functional differences between paralogous miRNAs with proper experimental methods. In this study, we compared the targets of paralogous miRNAs, miR-221 and miR-222. Using a nuclease-mediated genome engineering technique, we established knockout cell lines for these miRNAs, and precisely analyzed differences in target regulation. We found that miR-221 and miR-222 suppress the previously identified targets, CDKN1B and CDKN1C, differentially. Whereas both miRNAs suppressed CDKN1B, only miR-221 suppressed CDKN1C. From transcriptome analyses, we found that several different target mRNAs were regulated by each of miR-221 and miR-222 independently, although a large number of mRNAs responded commonly to miR-221 and miR-222. This is the first study to compare the mRNA regulations by paralogous miRNAs and illustrate that paralogous miRNAs with the same seed sequence also have difference in target regulation.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [41] miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
    Quintavalle, C.
    Garofalo, M.
    Zanca, C.
    Romano, G.
    Iaboni, M.
    De Caro, M. del Basso
    Martinez-Montero, J. C.
    Incoronato, M.
    Nuovo, G.
    Croce, C. M.
    Condorelli, G.
    ONCOGENE, 2012, 31 (07) : 858 - 868
  • [42] The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma
    Jikuzono, Tomoo
    Kawamoto, Masashi
    Yoshitake, Hiroshi
    Kikuchi, Kunio
    Akasu, Haruki
    Ishikawa, Hitoshi
    Hirokawa, Mitsuyoshi
    Miyauchi, Akira
    Tsuchiya, Shinichi
    Shimizu, Kazuo
    Takizawa, Toshihiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (06) : 1858 - 1868
  • [43] In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
    Di Martino, Maria Teresa
    Gulla, Annamaria
    Cantafio, Maria Eugenia Gallo
    Lionetti, Marta
    Leone, Emanuela
    Amodio, Nicola
    Guzzi, Pietro Hiram
    Foresta, Umberto
    Conforti, Francesco
    Cannataro, Mario
    Neri, Antonino
    Giordano, Antonio
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    ONCOTARGET, 2013, 4 (02) : 242 - 255
  • [44] Oncogenic KRAS Regulates miR-200c and miR-221/222 in a 3D-Specific Manner in Colorectal Cancer Cells
    Tsunoda, Toshiyuki
    Takashima, Yasuo
    Yoshida, Yasuhiro
    Doi, Keiko
    Tanaka, Yoko
    Fujimoto, Takahiro
    Machida, Takashi
    Ota, Takeharu
    Koyanagi, Midori
    Kuroki, Masahide
    Sasazuki, Takehiko
    Shirasawa, Senji
    ANTICANCER RESEARCH, 2011, 31 (07) : 2453 - 2459
  • [45] Quantitative proteomics reveals that miR-222 inhibits erythroid differentiation by targeting BLVRA and CRKL
    Jiang, Li
    Wang, Xing
    Wang, Yong
    Chen, Xiaoyan
    CELL BIOCHEMISTRY AND FUNCTION, 2018, 36 (02) : 95 - 105
  • [46] Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines
    Mari, Emanuela
    Zicari, Alessandra
    Fico, Flavia
    Massimi, Isabella
    Martina, Lolli
    Mardente, Stefania
    ONCOLOGY LETTERS, 2016, 12 (03) : 2133 - 2138
  • [47] miR-221/222在肿瘤诊治中的研究进展
    龙斌
    李林法
    易贺庆
    中国基层医药, 2016, 23 (16) : 2542 - 2545
  • [48] Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
    Karakatsanis, Andreas
    Papaconstantinou, Ioannis
    Gazouli, Maria
    Lyberopoulou, Anna
    Polymeneas, George
    Voros, Dionysios
    MOLECULAR CARCINOGENESIS, 2013, 52 (04) : 297 - 303
  • [49] miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
    Xu, Qinhong
    Li, Pei
    Chen, Xin
    Zong, Liang
    Jiang, Zhengdong
    Nan, Ligang
    Lei, Jianjun
    Duan, Wanxing
    Zhang, Dong
    Li, Xuqi
    Sha, Huanchen
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    ONCOTARGET, 2015, 6 (16) : 14153 - 14164
  • [50] miR-221和miR-222在子宫颈鳞癌组织中的表达及与其p27蛋白表达的关系
    胡芝
    李玲玲
    吕杰强
    张丽芳
    薛向阳
    柯晓慧
    王弋
    中华妇产科杂志, 2010, (12)